SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

A sharp AVAX rebound has pushed the token into focus, with traders citing growing institutional and real-world-asset adoptionincluding reported tokenization initiatives and expanded financial-platform accessas a potential catalyst. Bullish participants see a breakout and renewed altcoin momentum, while skeptics argue the move lacks volume and may fade amid continued selling pressure and tokenomics concerns.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

A reported U.S.-Denmark-Greenland security agreement has driven attention to CRML because traders view Greenlands strategic importance as potentially supportive of the Tanbreez rare-earth project. The community is largely bullish and discussing short-covering potential, although some traders caution that the agreement does not change the projects development timeline, funding needs, or mining execution risks.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

Repeated Sui mainnet outages and network stalls, alongside concerns about token unlocks and inflationary tokenomics, are driving debate around SUI. Bulls point to gasless stablecoin transfers, staking and institutional adoption as longer-term positives, while skeptics question the networks reliability and sell-side pressure.

VeChain is a public Layer-1 blockchain designed for real-world applications. Founded in 2015, its VeChainThor network supports enterprise and consumer use cases involving supply chains, product provenance, sustainability, digital product passports, tokenized incentives and verifiable data.  VeChainThor combines EVM-compatible smart contracts with a dual-token model, native fee delegation and multi-clause transactions. VET is the network’s native asset and staking collateral, while VTHO is used to pay transaction fees and execute smart contracts.  VeChain’s ecosystem includes VeBetter, an app platform that rewards verified positive actions; StarGate, its NFT-based staking platform; VeWorld, its self-custody wallet; and VeWorld.ai, its AI-agent platform. In its April 2026 roadmap, VeChain reported that VeBetter had reached 5.3 million users, more than 50 live applications and over 50 million verified actions.  VeChain has also worked with organizations including Walmart China, DNV, PwC, Boston Consulting Group and UFC across enterprise, sustainability and consumer initiatives.

Vechain

VeChains Interstellar (VIP-255) mainnet upgrade is driving attention, with traders focused on its expanded Ethereum compatibility, smart-contract tooling, and potential to attract developers and network activity. Bulls view the upgrade as a major Renaissance milestone and cite the recent breakout, while skeptics argue the technical progress has not yet translated into meaningful price performance or adoption.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is drawing attention after a sharp rebound and technical breakout, with traders highlighting renewed momentum, strong support, and broader crypto-market strength. The main debate centers on whether anticipated U.S. crypto-regulation clarity and growing tokenization/ETF interest can extend the move, while skeptics cite rate-hike risk and possible legislative failure.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Quarterly results and the reaffirmation of full-year guidance are driving attention, with traders debating whether stronger VEVYE coverage and IHEEZO demand can offset concerns about revenue execution, pricing, and managements forecasting credibility. Long-term holders view the ophthalmology portfolio and second-half growth outlook as an inflection point, while skeptics remain focused on potential guidance risk and inconsistent delivery.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Earnings commentary highlighting declining same-store sales and a projected domestic sales decline has intensified concerns about Wingstops exposure to weaker consumer spending, inflation, and rising operating costs, contributing to repeated 52-week lows. Traders are divided between viewing the selloff as an overreaction to cyclical restaurant pressurewith franchise growth and expansion still intactand expecting further downside if traffic and value perception do not improve.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Surging refining margins, particularly elevated diesel crack spreads amid global refinery outages and geopolitical supply disruptions, are driving Valeros rally to repeated 52-week and all-time highs. Traders remain divided, with bullish participants citing tight refined-product supply while others warn the stock is overbought and vulnerable to falling crack spreads, profit-taking, or a technical pullback.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

A Swedish Space Corporation contract for two Alpha launches from Esrange is drawing attention, alongside discussion of Fireflys production ramp and expanding launch backlog. Traders are divided because the positive contract news has been accompanied by weak price action and underperformance versus other space stocks.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Anticipation of further FLAMINGO-01 clinical updatesparticularly open-label recurrence data and the path to an interim analysisis driving attention, with traders also speculating about a potential licensing or partnership deal. Bullish participants cite encouraging prior efficacy signals, expanded enrollment, and insider conviction, while skeptics focus on the redesigned trials longer timeline, financing needs, and dilution risk; the thin float and short interest are amplifying volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SBC Medical Group Holding Q2 2026 Earnings Call Transcript

SBC Medical Group Holding (NASDAQ:SBC) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call.
Benzinga APIs provide real-time access to earnings call transcriptsread more...

SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (The Company or SBC Medical), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in September 2026. SBC Medical...

SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (SBC Medical or the Company), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields to medical institutions in Japan and abroad, today announced its consolidated financial results for the...

SBC Medical Group Holdings Announces First Quarter 2026 Financial Results

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (SBC Medical or the Company), a Medical Services Organization providing management support across a wide range of healthcare fields, today...

Yoshiyuki Aikawa Sells 465,000 Shares of SBC Medical Group (NASDAQ:SBC) Stock

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) CEO Yoshiyuki Aikawa sold 465,000 shares of the stock in a transaction on Tuesday, April 28th. The stock was sold at an average...

Insider Selling: SBC Medical Group (NASDAQ:SBC) CEO Sells 465,000 Shares of Stock

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) CEO Yoshiyuki Aikawa sold 465,000 shares of the firm's stock in a transaction on Tuesday, April 28th. The stock was sold at an...

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) Short Interest Update

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totaling...

SBC Medical Group (NASDAQ:SBC) CEO Yoshiyuki Aikawa Sells 3,100,000 Shares

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) CEO Yoshiyuki Aikawa sold 3,100,000 shares of the stock in a transaction that occurred on Tuesday, April 21st. The shares were...

Yoshiyuki Aikawa Sells 3,100,000 Shares of SBC Medical Group (NASDAQ:SBC) Stock

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) CEO Yoshiyuki Aikawa sold 3,100,000 shares of the business's stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at an average price of $3.02, for a total value of $9,362,000.00. Following the...

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (the Company), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced...

SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company was founded on January 20, 2023 and is headquartered in Irvine, CA.

SBC Medical Group Holdings Inc.

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$4.75
Prev Close	$4.69
Open	$4.78
Dividend Yield	0.00%
50-Day Moving Average	$3.64
Beta	0.36
Avg. Volume	176,926.58
PE Ratio	9.94

52-Week High	$4.97
52-Week Low	$2.78
Market Capitalization	$488.52M
EPS (Annual)	$0.495
Price to Book	1.85
Revenue Per Employee	$201,167.43

Feed

News

Sentiment

Earnings

Fundamentals

Info

SBC Fundamentals